Although medication overload is particularly prevalent in older adults, younger people are not immune to harm from overprescribing, particularly when it comes to drugs for psychiatric conditions. Here is one person's story of harm from the psychiatric drug prescribing cascade. More
Can we trust drug companies to monitor and regulate the safety of their own products? More
Should patients be on the hook for ambulance rides for non-emergencies? It's not that simple, write Dr. Surafel Tsega and Dr. Harry Cho in JAMA. More
How health care institutions can address social determinants of health, beyond just screening and referral. More
Why decision aids aren't affecting patients' decisions about prostate cancer screening... More
It's not the hospitals you might expect... More
A recent CBS "Whistleblower" segment misses the big picture on midwives and maternity care. More
The latest commentary in the Lown Institute and American Family Physician's "Right Care" series features Dr. Andy Lazris and Dr. Alan Roth on the pros and cons of lung cancer screening. More
What happens when one low-value test leads to a "cascade" of expensive and harmful procedures? More
We know that consolidation among hospitals and insurance companies leads to higher prices. But what about consolidation in other areas of health care? More
Why measuring the outcomes of deprescribing is key for culture change, from family physician Maisha Draves at Kaiser Permanente. More
Is the FDA's accelerated approval program resulting in better cancer drugs? Two new studies provide insight... More
The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More
While we rush to fix the opioid crisis, are we ignoring another widespread drug problem? More
A group of pharmacists from Lifespan/Rhode Island Hospital answer our questions about how pharmacists can promote deprescribing. More
Is our health care system prepared to treat more behavioral health problems in younger people? So far, the answer is no. More
Health care experts explain the potential downsides to the artificial intelligence "revolution." More
In Health Affairs Grantwatch blog, Shannon Brownlee and Terry Fulmer describe how the Lown Institute and John A. Hartford Foundation are working together to reduce medication overload. More
Popular health news often fails to reflect the incrementalism and nuance of medical discoveries, instead hyping unproven treatments. Can we save health journalism? More
Much of the political discourse around health focuses on expanding access to health insurance. But how much does health care really matter for health? More